Subscribe Now Subscribe Today
Research Article
 

In vitro Inhibition of Mastitis Pathogens by Bacteriocin RN 86 Produced by an Indigenous Lactobacillus casei Isolate



Naheed Mojgani and Mehdi Perveen Ashtiani
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

A broad-spectrum bacteriocin produced by L. casei RN 86 was a stable and relatively small molecule (5.5 KDa) being bactericidal againsta range of mastitis-causing bacterial pathogens. The antimicrobial activity of the peptide against the sensitive cells was 10 fold increased (AU mL-1) after partial purification by 20% ammonium sulphate precipitation. The partially purified peptide indicated to be bactericidal against S. aureus and S. agalactiae cells and killed approximately 106 to 109 of the actively growing sensitive cells within an hour of incubation. It caused rapid cessation of the growth of the sensitive strains within few minutes of contact, while almost 99.9% of the cells were killed within an hour of incubation with 10240 AU mL-1 of its concentrations. Owing to the wide spectrum activity, efforts were made to investigatethe in vitro efficacy of this antibacterial compound in combination with a teat seal formulation, against mastitis pathogens. A new prototype formulation containing the bacteriocin RN 86 with or without minimum concentrations of antibiotics and tween 80, which were the active ingredients of a teat seal used for the treatment of bovine mastitis. The results showed synergistic effect of all three components in combination and were the most effective in controlling the growth of Staphylococcus aureus and Streptococcus agalactiae during in vitro experiments.

Services
Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

Naheed Mojgani and Mehdi Perveen Ashtiani , 2006. In vitro Inhibition of Mastitis Pathogens by Bacteriocin RN 86 Produced by an Indigenous Lactobacillus casei Isolate. Journal of Applied Sciences, 6: 2629-2634.

DOI: 10.3923/jas.2006.2629.2634

URL: https://scialert.net/abstract/?doi=jas.2006.2629.2634

REFERENCES
1:  Broadbent, J.R., C. Chou, K. Gillies and J.K. Kondo, 1989. Nisin inhibits several gram-positive, mastitis-causing pathogens. J. Dairy Sci., 72: 3342-3345.
Direct Link  |  

2:  Cleveland, J., T.J. Montville, I.F. Nes and M.L. Chikindas, 2001. Bacteriocins: Safe, natural antimicrobials for food preservation. Int. J. Food Microbiol., 71: 1-20.
CrossRef  |  PubMed  |  Direct Link  |  

3:  Coakley, M., G.F. Fitzgerald and R.P. Ross, 1997. Application and evaluation of the phage resistance- and bacteriocin-encoding plasmid pMRC01 for the improvement of dairy starter cultures. Applied Environ. Microbiol., 63: 1434-1440.
PubMed  |  Direct Link  |  

4:  Craven, N., 1987. Efficacy and financial value of antibiotic treatment of bovine clinical mastitis during lactation a review. Br. Vet. J., 143: 410-422.
PubMed  |  Direct Link  |  

5:  Delves-Brougthon, J., 1990. Nisin and its uses as a food preservative. Food Technol., 44: 100-112.
Direct Link  |  

6:  Giacometti, A., O. Cirioni and M.S. Del-Prete, 2000. Combination studies between polycationic peptides and clinically used antibiotics against gram positive and gram negative bacteria. Peptides, 21: 1155-1160.
PubMed  |  Direct Link  |  

7:  Guerra, N.P and L.P. Castro, 2002. Production of bacteriocins from lactococcus lactis CECT 539 and Pediococcus acidilactici NRRL B-5627 using mussel processing wastes. Biotechnol. Applied Biochem., 36: 119-125.
Direct Link  |  

8:  Hancock, R.E.W. and D.S. Chapple, 1999. Peptide antibiotics. Antimicrob. Agents Chemother., 43: 1317-1323.
CrossRef  |  Direct Link  |  

9:  Ingham, A., M. Ford, R.J. Moore and M. Tizard, 2003. The bacteriocin piscicolin 126 retains antilisterial activity in vivo. J. Antimicrob. Chemother., 51: 1365-1371.
Direct Link  |  

10:  Mayr-Hartings, A., A.J. Hedges and R.C.W. Berkeley, 1992. Methods for studying bacteriocins. Meth. Microbiol., 7: 315-422.

11:  McAuliffe, O., M.P. Ryan, R.P. Ross, C. Hill, P. Breeuwer and T. Abee, 1998. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Applied Environ. Microbiol., 64: 439-445.
Direct Link  |  

12:  Meaney, W.J., 1977. Effect of dry period teat seal on bovine udder infection. Ir. J. Agric. Res., 16: 293-299.

13:  Meaney, W.J., D.P. Twomey, H.C. Flynn and R.P. Ross, 2001. The use of a bismuth based teat seal and the bacteriocin lacticin 3147 to prevent dry period mastitis in dairy cows. Proceedings of British Mastitis Conference, (BMC'2001), Garstang, pp: 293-299.

14:  Minahk, C.J., F. Dupuy and R.D. Morero, 2004. Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL 35. J. Antimicrob. Ther., 53: 240-246.
Direct Link  |  

15:  Morgan, S.M., P.M. O'Connor, P.D. Cotter, R.P. Ross and C. Hill, 2006. Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrobial. Agents Chemother., 49: 2606-2611.
CrossRef  |  Direct Link  |  

16:  Oldham, E.R. and M.J. Daley, 1991. Lysostaphin: Use of a recombinant bactericidal enzyme as mastitis therapeutic. J. Dairy Sci., 74: 4175-4182.
Direct Link  |  

17:  Ryan, M.P., R.W. Jack, M. Josten, H.G. Sahl, G. Jung, R.P. Ross and C. Hill, 1999. Extensive post-translational modification, including serine to D-Alanine conversion, in the two-component lantibiotic, lacticin 3147. J. Biol. Chem., 274: 37544-37550.
Direct Link  |  

18:  Sears, P.M., D.J. Wilson and R.N. Gonzalez, 1992. The potential role of antimicrobial proteins in the treatment of bovine mastitis. Proceedings of the American Association of Bovine Practitioners Conference, Aug. 31-Sept. 4, USA., pp: 138-142.

19:  Sears, P.M., J. Peele, M. Lassauzet and P. Blackburn, 1995. Use of antimicrobial proteins in the treatment of bovine mastitis. Proceedings of 3rd Internationl Mastitis Seminar, (IMS'1995), Tel Aviv, Israel, pp: 17-18.

20:  Takahiro, T., Y. Emiko and I. Takatoshi, 1991. Lacticin, a bacteriocin produced by Lactobacillus delbrueckii sub sp. Lactis. Lett. Applied Microbiol., 12: 43-45.

21:  Van Veen, H., A. Margolles and M. Putman, 1999. Multidrug resistance in lactic acid bacteria: Molecular mechanisms and clinical relevance. Antonie Van Leeuwenhoek, 76: 347-352.
CrossRef  |  Direct Link  |  

22:  Wirawan, R.E., N.A., Klesse, R.W. Jack and J.R. Tagg, 2006. Molecular and genetic characterization of a novel nisin variant produced by streptococcus uberis. Applied Environ. Microbiol., 72: 1148-1156.
CrossRef  |  Direct Link  |  

23:  Schagger, H. and G. von Jagow, 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem., 166: 368-379.
CrossRef  |  PubMed  |  Direct Link  |  

©  2021 Science Alert. All Rights Reserved